Links
Organizations
Conferences
Info & Opinion
- Applied Clinical Trials
- Bio-IT World
- ClinPsych
- Clinical Trials Today
- Tom Lamb
- George Laszlo
- Pharma Voice
- Ed Silverman
- TJOLS
December 3, 2008
Low Interest So Far
Microdosing Update From FDA
Yes, microdosing is part of the FDA’s Critical Path Initiative. But no, sponsors don’t seem to be interested in extremely low-dose trials yet. Why? The FDA’s David Jacobson-Kram offers some thoughts.
- Home
- Tag
- microdose
Despite the fact that some European biotechs have been touting microdosing as the next big thing, sponsors in the U.S. are still not rushing out in great numbers to give the extremely low-dose trials a whirl. In fact, says the…
No articles available
